OCGN News and Press, Ocugen, Inc. From 04/14/24

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Ocugen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 14, 2024) - Faruqi & Faruqi, LLP, a leading national se...

2024-04-12 14:30:00 ET Summary Introducing a new recurring series to help you sift through ideas and data on the site: The "Undercovered" Dozen. In this monthly series, we'll cover twelve ideas from the previous month on stocks that receive limited coverage across Seeking Alpha. ...

NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ocugen, Inc. ("Ocugen" or "the Company") (NASDAQ:OCGN). Investors who purchased Ocugen securities are encouraged to obtain additional information and a...

2024-04-10 10:20:34 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Ocugen stock gains after FDA nod to initiate Phase 3 trial of gene therapy candidate Ocugen advances Phase 1/2 trial for eye disease candidat...

MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Committee for...

2024-04-08 07:10:32 ET Ocugen ( NASDAQ: OCGN ) shares gained 7% premarket on Monday after the U.S. Food and Drug Administration (FDA) cleared the firm’s investigational new drug amendment to initiate a late-stage clinical trial of its gene therapy product candidate......

MALVERN, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the U.S. Food and...

2024-04-07 04:06:09 ET Ocugen (NASDAQ: OCGN) stock price has been one of the best-performing companies in Wall Street this year. It has jumped by more than 218% in 2024, beating some of the best-known brands like Nvidia and Amazon. This surge has boosted its total market cap to over $46...

2024-04-06 06:13:00 ET 3 Top Strategies to Trade Options With Penny Stocks in 2024 Trading penny stocks through options presents a dynamic avenue for investors looking to enhance their portfolios with high-potential, yet affordable securities. The intersection of options trading and p...

2024-04-05 10:56:25 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Ocugen slips as accounting errors force restatements Ocugen shares make gains after US court dismisses class action lawsuits Seeking ...